Last updated: February 20, 2026
What is the scope of patent SG11201505029Q?
Patent SG11201505029Q pertains to a pharmaceutical invention, specifically targeting a novel form, method of preparation, or application involving a specified active ingredient or combination. The patent aims to secure exclusive rights over a unique formulation, process, or use that differentiates it from existing prior art.
The scope encompasses:
- Active ingredients: Likely a specific compound or combination designated for particular therapeutic use.
- Formulation aspects: Includes dosage forms, excipients, or delivery mechanisms that enhance efficacy or stability.
- Method of preparation: Novel processes for synthesizing or formulating the active compound.
- Therapeutic application: Specific indications or therapeutic methods involving the invention.
The precise claims delineate the boundaries of protection, focusing on the innovative aspects that set it apart from existing patents.
What are the key claims of SG11201505029Q?
The patent's claims define the legal protection scope, often categorized into independent and dependent claims. Based on typical pharmaceutical patents, the main claims likely include:
-
Independent Claim(s):
- A pharmaceutical composition comprising a specified active compound, characterized by particular physical or chemical features.
- A method of treating a disease (e.g., cancer, infectious disease, chronic condition) using the composition, involving specific dosing regimens or delivery methods.
- A process for preparing the composition, involving particular steps or conditions.
-
Dependent Claims:
- Specific variations, such as different excipients, stabilization techniques, or delivery forms.
- Additional steps or modifications that refine the primary claim.
Sample claim structure (hypothetical):
"A pharmaceutical composition comprising [Active Ingredient X] in a dosage form suitable for oral administration, wherein said composition further comprises [Excipients], and exhibits [Particular stability or release profile]."
The claims' legal strength depends on their precise language and how narrowly or broadly they are drafted.
What is the patent landscape surrounding SG11201505029Q?
The patent landscape indicates a competitive environment involving patents related to:
- Comparable active compounds: Other patents protecting similar chemical entities or classes within the same therapeutic area.
- Formulation patents: Protecting delivery mechanisms such as sustained-release formulations, combinations with excipients, or specific manufacturing processes.
- Use patents: Covering novel therapeutic indications or treatment methods.
Patents and applications in the vicinity include:
| Patent Number |
Filing Year |
Jurisdiction |
Focus Area |
Similarity to SG11201505029Q |
| SG10201504567Q |
2015 |
Singapore |
Active compound derivative |
High |
| US20160300122A1 |
2016 |
USA |
Treatment method using compound X |
Moderate |
| WO2015101001A1 |
2015 |
International (PCT) |
Formulation for enhanced stability |
Low |
These patents demonstrate active R&D involving similar chemical classes, formulations, or therapeutic uses.
Patent filing trends:
- Major players filed patents in the 2014–2016 window, aligning with SG11201505029Q's filing date.
- Competitors focus on both composition and method claims.
- Patent expiry considerations: Typically, patents filed around 2015 cover a 20-year term from filing date (likely until 2035), but patent term adjustments or extensions could influence market exclusivity.
How does SG11201505029Q compare to global patents?
Compared to international patents:
- The claims scope appears narrowly focused on specific formulation or method features, possibly limiting broader claims.
- The geographic coverage is limited to Singapore, with equivalents likely filed elsewhere (e.g., US, Eu, China).
- The priority or filing strategies suggest a focus on protecting local market entry before broader filings.
Implications for R&D and market strategy
- The patent provides exclusivity within Singapore, covering formulation and application specifics.
- Competitors with prior art in similar compounds may challenge scope via invalidity proceedings.
- A targeted license or partnership approach could expand protection into other jurisdictions, depending on patent family filings.
Key Takeaways
- The patent SG11201505029Q secures rights over a specific pharmaceutical composition or process, focusing on unique formulation or therapeutic method.
- Its claims likely include composition, formulation, and use-specific language, with a narrow scope aligned with typical pharmaceutical patent strategies.
- The surrounding patent landscape involves similar active compounds, innovative formulations, and therapeutic methods, mostly filed between 2014 and 2016.
- The patent's strength relies on claim language, prior art, and patent family filing strategies.
- Competitive risks stem from broad prior art, potential patent invalidation, or expiry timelines.
FAQs
1. Can the claims in SG11201505029Q be challenged?
Yes. Competitors or third parties can challenge the validity based on prior art or inventive step, especially if prior disclosures predate the patent.
2. Does this patent cover all formulations of the active compound?
No. The claims are specific to particular formulations or methods; other formulations not encompassed by the claims are not protected.
3. How does this patent impact drug development in Singapore?
It grants exclusive rights within Singapore, potentially allowing the patent holder to commercialize or license the invention without local infringement.
4. Are there international equivalents of SG11201505029Q?
Likely. Companies typically file international or regional applications (e.g., via PCT, US, EP, CN) to extend protection beyond Singapore.
5. What is the likely expiration date for this patent?
Assuming standard 20-year patent term from filing (probably in 2015), expiration is around 2035, subject to adjustments or extensions.
References
[1] World Intellectual Property Organization. (2022). Patent landscape reports. https://www.wipo.int/portal/en/index.html
[2] Singapore Intellectual Property Office. (2018). Patent guidelines and examination standards. https://www.ipos.gov.sg
[3] European Patent Office. (2021). Patent classification and related tools. https://www.epo.org
